Länder Analysen: Schweiz
| 30.03.23 | DocMorris Underperform | Credit Suisse Group | |
| 30.03.23 | Givaudan Underweight | Barclays Capital | |
| 29.03.23 | Givaudan Sell | UBS AG | |
| 29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 27.03.23 | Givaudan Underperform | Jefferies & Company Inc. | |
| 27.03.23 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 23.03.23 | DocMorris Sell | UBS AG | |
| 21.03.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
|
Werbung
|
|||
| 14.03.23 | Novartis Sell | Deutsche Bank AG | |
| 08.03.23 | DocMorris Underperform | Credit Suisse Group | |
| 08.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.03.23 | Holcim Sell | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.03.23 | Swiss Re Sell | UBS AG | |
| 06.03.23 | Nestlé Underperform | RBC Capital Markets | |
| 03.03.23 | Zurich Insurance Underweight | JP Morgan Chase & Co. | |
| 27.02.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 24.02.23 | Holcim Sell | Goldman Sachs Group Inc. | |
| 22.02.23 | Givaudan Underweight | Barclays Capital | |
| 21.02.23 | Swiss Re Sell | UBS AG | |
| 20.02.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 17.02.23 | Novartis Sell | Deutsche Bank AG | |
| 17.02.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |
| 16.02.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 15.02.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 14.02.23 | Roche Sell | Deutsche Bank AG | |
| 09.02.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
| 09.02.23 | DocMorris Underperform | Credit Suisse Group | |
| 09.02.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 07.02.23 | DocMorris Sell | UBS AG | |
| 07.02.23 | Novartis Sell | Deutsche Bank AG | |
| 06.02.23 | DocMorris Sell | UBS AG | |
| 06.02.23 | Roche Sell | Deutsche Bank AG | |
| 03.02.23 | Roche Sell | Deutsche Bank AG | |
| 02.02.23 | Novartis Underperform | Credit Suisse Group | |
| 02.02.23 | Novartis Sell | Deutsche Bank AG | |
| 02.02.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 01.02.23 | UBS Underweight | Barclays Capital | |
| 31.01.23 | Givaudan Sell | UBS AG | |
| 30.01.23 | Givaudan Underweight | Barclays Capital | |
| 25.01.23 | Givaudan Underweight | JP Morgan Chase & Co. | |
| 25.01.23 | Givaudan Underperform | Jefferies & Company Inc. | |
| 25.01.23 | Givaudan Sell | UBS AG | |
| 25.01.23 | Givaudan Underperform | Bernstein Research | |
| 25.01.23 | Novartis Underweight | Barclays Capital | |
| 20.01.23 | Givaudan Underweight | Barclays Capital | |
| 20.01.23 | DocMorris Sell | UBS AG | |
| 19.01.23 | DocMorris Sell | UBS AG | |
| 19.01.23 | Roche Underweight | JP Morgan Chase & Co. | |
| 19.01.23 | Roche Sell | Deutsche Bank AG | |
| 18.01.23 | Swiss Re Sell | Goldman Sachs Group Inc. | |